Market Currents
Achillion (ACHN +4.6%) gains on a price target increase to $17 from $12 at Deutsche Bank. The...
-
Tuesday, October 16, 2012, 12:36 PM ETAchillion (ACHN +4.6%) gains on a price target increase to $17 from $12 at Deutsche Bank. The firm says liver abstracts from Bristol-Myers (BMY +0.6%) and Abbott (ABT +0.1%) bode well for the future success of ACHN's two drug combo regimens for the treatment of hepatitus C virus. The firm made similar comments yesterday about Gilead (GILD +1.6%).
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
